Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.038
-0.028 (-2.63%)
At close: Oct 10, 2025
-2.63%
Market Cap2.09B
Revenue (ttm)n/a
Net Income (ttm)-78.10M
Shares Out2.01B
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,635,760
Average Volume9,147,884
Open1.044
Previous Close1.066
Day's Range0.987 - 1.060
52-Week Range0.155 - 1.068
Beta1.61
RSI69.71
Earnings DateOct 23, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.